|
|
BioBusiness Network 2008
Uncover Deal Opportunities And Position Yourself As Partner Of Choice At A Time Of Market Uncertainty
'BioBusiness Network delivered on all counts: a senior audience, informative presentations and an informal atmosphere for successful partnering'
Paul Higham, Director of Commercial Development, Ark Therapeutics
Never has successful bio-partnering been more critical. Expiring patents, dry pipelines, fragmenting prescriber groups and escalating regulations mean only the most scientifically successful and commercially creative organisations will flourish.
BioBusiness offers a unique and exclusive environment to ensure you meet with the partners who will transform your business. Join over 250 senior bio-partnering professionals at intensive one-to-one meetings, insightful presentations, thought-provoking roundtables, elegant drinks receptions and gourmet dinners.
Confirmed Speakers for Biobusiness Networks 2008 include:
- Jose Carlos Gutierrez-Ramos,SVP and Head of Immuno-Inflammation CEDD, GlaxoSmithKline
- JKlaus Wilgenbus, Corporate Senior Vice President Licensing, Boehringer Ingelheim
- Tobias Keichle, Global Head of Alliance Management, Roche
- Joern-Peter Halle, Head of Early Stage Licensing, Merck Serono
- Robert Smith,Senior Vice President, Mergers and Acquisitions, Wyeth Pharmaceuticals
- James Williams, Director, Business Development, Roche
- Dr Nigel Finch, Global Marketing, AstraZeneca
- Knut Sturmhoefel, Alliance Management, Novartis
- Jeremy Carmichael, Director of Business Development, Astex
- Tobias Keichle, Head of Alliance Management, Roche
- Onno van de Stolpe, CEO, Galapogos
- David Colpman, SVP Business Development, Shire
- Elias Papatheodorou, CEO, Novosom
- Morten Faester, Senior Director Business Development, Nycomed
- Denise Good, Executive Director, Business Development, AstraZeneca
- John Cantello, Director, Business Development, GSK
- Ruth Keir, Executive Director, Business Development, Pfizer
- Hayley French, Senior Legal Council, Novartis
- Tony Chen, Partner, Jones Day
- Darren Ji, CEO, PharmaLegacy
- Dr Koteswara Rao Kollipara, Managing Director, Transgene Biotek
- Gary Deeb, VP Business Development, Glenmark Pharma
- Tarmo Kivi, CEO, Celcure Biotech
- Veronique Bouchet, Head of Venture Strategy, AstraZeneca
- Andrew Wood, Executive Director Global External Research, Eli Lilly
- Sarah Garner, Associate Director, Research & Development, NICE
- Dr Simon Best, Chairman, Ardana
- Dr Klaus Wilgenbus, Corporate Senior Vice President Licensing, Boehringer Ingelheim
- Elias Papatheodorou, CEO, Novosom
- Dr Frank Morich, CEO, Noxxon
- Dr Kleanthis Xanthopoulos, CEO, Regulus
- Nick Adams, Director, Business Development, Antisoma
- Jean-Francois Mouney, CEO, Genfit
- Michael Hunt, CEO, Reneuron
Why Book for BioBusiness Network 2008?
- Don’t miss the top deal presentations from Roche/Piramed, GSK/Regulus and Merck Serono/Archemix
- Take part in roundtables throughout the conference to make sure you get the most out of your networking time
- Find out more about your partners and competitors at the Partnering Skills Focus day on 16th September
- Meet with over 15 biotechs and pharma from key emerging markets at our exclusive focus day
- Network with top 10 pharma including ROCHE, GSK, ASTRAZENECA, NOVARTIS, PFIZER, LILLY AND WYETH as well as leading European and US biotech CEOs
What’s New And Improved At BioBusiness Network 2008?
- Roundtables throughout the conference. Your objective in attending BioBusiness Network is to meet with potential partners engaged in (or interested in entering) your therapeutic field. At first glance this isn’t always easy to find, which is why BioBusiness Network makes it easy for you.
- After each presentation in the therapeutic and innovation streams, we’re inviting you to join your peers at a roundtable discussion. You will be able to put your questions to speakers and expand your network in a comfortable and business-focused environment.
- Emerging Markets Focus Day. As big pharma invest more and more in China, you need to understand the importance of key emerging markets and their potential for you. We’ve brought together experts from key BRIC countries to speak about investing and partnering in these hot new regions.
- Partnering Skills Focus. What could be more useful than knowing the processes your partners (and competitors) have in place to ensure their deals are successful? Join big pharma and biotech to discuss the key criteria for a smooth deal process and uncover best practice examples from your peers.
If you are interested in Speaking at BioBusiness Network 2008, please contact Frances Parker at frances.parker@wbr.co.uk or call on+44 207 3689464
To purchase the BioBusiness Network 2008 CD ROM (all presentations included), contact Meg Godfrey on +44 (0) 20 7368 9465
 |
 |
2007 Award Winners |
Enjoy a gourmet Networking Dinner |
 |
Relax and enjoy informal networking over a glass of champagne |
Sponsorship Opportunities
To learn more about sponsorship opportunities at BioBusiness Network 2008 please contact Joseph Cleary on +44 (0)207 368 9527 or email joseph.cleary@wbr.co.uk